DELCATH SYSTEMS INC (DCTH)
US24661P8077 - Common Stock
Taking everything into account, DCTH scores 3 out of 10 in our fundamental rating. DCTH was compared to 196 industry peers in the Health Care Equipment & Supplies industry. DCTH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, DCTH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year DCTH has reported negative net income.
In the past year DCTH has reported a negative cash flow from operations.
In the past 5 years DCTH always reported negative net income.
DCTH had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -123.47%, DCTH is doing worse than 86.22% of the companies in the same industry.
DCTH has a worse Return On Equity (-302.19%) than 82.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -123.47% | ||
| ROE | -302.19% | ||
| ROIC | N/A |
ROA(3y)-135.11%
ROA(5y)-107.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DCTH has a Gross Margin of 69.50%. This is amongst the best in the industry. DCTH outperforms 80.10% of its industry peers.
DCTH's Gross Margin has been stable in the last couple of years.
DCTH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.5% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.2%
GM growth 5Y-0.32%
2. Health
2.1 Basic Checks
DCTH does not have a ROIC to compare to the WACC, probably because it is not profitable.
DCTH has more shares outstanding than it did 1 year ago.
DCTH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DCTH has been reduced compared to a year ago.
2.2 Solvency
DCTH has an Altman-Z score of -17.95. This is a bad value and indicates that DCTH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -17.95, DCTH is not doing good in the industry: 85.20% of the companies in the same industry are doing better.
DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -17.95 |
ROIC/WACCN/A
WACC10.13%
2.3 Liquidity
A Current Ratio of 2.26 indicates that DCTH has no problem at all paying its short term obligations.
With a Current ratio value of 2.26, DCTH is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
A Quick Ratio of 2.06 indicates that DCTH has no problem at all paying its short term obligations.
The Quick ratio of DCTH (2.06) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.26 | ||
| Quick Ratio | 2.06 |
3. Growth
3.1 Past
DCTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.73%, which is quite impressive.
Looking at the last year, DCTH shows a very negative growth in Revenue. The Revenue has decreased by -24.21% in the last year.
The Revenue has been decreasing by -9.54% on average over the past years.
EPS 1Y (TTM)25.73%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q52.94%
Revenue 1Y (TTM)-24.21%
Revenue growth 3Y7.77%
Revenue growth 5Y-9.54%
Revenue growth Q2Q-15.78%
3.2 Future
The Earnings Per Share is expected to grow by 20.21% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 143.14% on average over the next years. This is a very strong growth
EPS Next Y56%
EPS Next 2Y38.98%
EPS Next 3Y33.33%
EPS Next 5Y20.21%
Revenue Next Year1147.83%
Revenue Next 2Y481.56%
Revenue Next 3Y300.8%
Revenue Next 5Y143.14%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for DCTH. In the last year negative earnings were reported.
Also next year DCTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
DCTH's earnings are expected to grow with 33.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.98%
EPS Next 3Y33.33%
5. Dividend
5.1 Amount
No dividends for DCTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DELCATH SYSTEMS INC
NASDAQ:DCTH (4/16/2024, 12:12:21 PM)
4.7418
-0.13 (-2.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap108.68M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -123.47% | ||
| ROE | -302.19% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.5% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.26 | ||
| Quick Ratio | 2.06 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)25.73%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y56%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-24.21%
Revenue growth 3Y7.77%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y